A client has been receiving MOPP (mechlorethamine, vincristine [Oncovin], procarbazine, prednisone) therapy for treatment of Hodgkin's disease. The treatment has changed to a protocol of ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, and dacarbazine). When the client asks the nurse for clarification about the change in protocol, the nurse's response will include that ABVD
A) can frequently produce a remission after only 1 cycle.
B) negates the need for radiation therapy.
C) prevents hypercalcemia.
D) reduces the risk of leukemia.

Question

Quizplus · Accepted Answer

The primary advantages of ABVD are its ease of delivery in full doses, fewer side effects, and less risk of development of leukemia.

A Client Has Been Receiving MOPP (Mechlorethamine, Vincristine [Oncovin], Procarbazine